Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-20-000105
Filing Date
2020-08-12
Accepted
2020-08-12 16:05:50
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20200630.htm   iXBRL 10-Q 1342070
2 EX-31.1 exhibit31120200630-ngv.htm EX-31.1 20074
3 EX-31.2 exhibit31220200630-ngv.htm EX-31.2 19796
4 EX-32.1 exhibit32120200630-ngv.htm EX-32.1 5294
5 EX-32.2 exhibit32220200630-ngv.htm EX-32.2 5282
11 dare-20200630_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-20-000105.txt   5699176

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20200630.xsd EX-101.SCH 43195
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20200630_cal.xml EX-101.CAL 51551
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20200630_def.xml EX-101.DEF 206604
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20200630_lab.xml EX-101.LAB 500541
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20200630_pre.xml EX-101.PRE 306894
12 EXTRACTED XBRL INSTANCE DOCUMENT dare-20200630_htm.xml XML 725922
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 201095495
SIC: 2834 Pharmaceutical Preparations